The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K + channels

Hibino, 2010, Inwardly rectifying potassium channels: their structure, function, and physiological roles, Physiol Rev, 90, 291, 10.1152/physrev.00021.2009 Abraham, 1999, Channelopathies of inwardly rectifying potassium channels, FASEB J, 13, 1901, 10.1096/fasebj.13.14.1901 Tristani-Firouzi, 2010, Kir 2.1 channelopathies: the Andersen–Tawil syndrome, Pflugers Arch, 460, 289, 10.1007/s00424-010-0820-6 Williams, 2010, Molecular basis of decreased Kir4.1 function in SeSAME/EAST syndrome, J Am Soc Nephrol, 21, 2117, 10.1681/ASN.2009121227 Pattnaik, 2012, Genetic defects in the hotspot of inwardly rectifying K(+) (Kir) channels and their metabolic consequences: a review, Mol Genet Metab, 105, 64, 10.1016/j.ymgme.2011.10.004 Kobayashi, 2004, Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs, Neuropsychopharmacology, 29, 1841, 10.1038/sj.npp.1300484 Kikuta, 2006, Carvedilol blocks cardiac KATP and KG but not IK1 channels by acting at the bundle-crossing regions, Eur J Pharmacol, 529, 47, 10.1016/j.ejphar.2005.10.059 Liu, 2007, Selective inhibition of Kir currents by antihistamines, Eur J Pharmacol, 558, 21, 10.1016/j.ejphar.2006.11.044 Ohno, 2007, Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors, Brain Res, 1178, 44, 10.1016/j.brainres.2007.08.018 Su, 2007, Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline, J Pharmacol Exp Ther, 320, 573, 10.1124/jpet.106.112094 Rodríguez-Menchaca, 2008, The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel, Proc Natl Acad Sci USA, 105, 1364, 10.1073/pnas.0708153105 Furutani, 2009, Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel, Mol Pharmacol, 75, 1287, 10.1124/mol.108.052936 Ponce-Balbuena, 2012, Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels, Mol Pharmacol, 82, 803, 10.1124/mol.112.079152 Takumi, 1995, A novel ATP-dependent inward rectifier potassium channel expressed predominantly in glial cells, J Biol Chem, 270, 16339, 10.1074/jbc.270.27.16339 Higashi, 2001, An inwardly rectifying K(+) channel, Kir4.1, expressed in astrocytes surrounds synapses and blood vessels in brain, Am J Physiol Cell Physiol, 281, C922, 10.1152/ajpcell.2001.281.3.C922 Marcus, 2002, KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential, Am J Physiol Cell Physiol, 282, C403, 10.1152/ajpcell.00312.2001 Rozengurt, 2003, Time course of inner ear degeneration and deafness in mice lacking the Kir4.1 potassium channel subunit, Hear Res, 177, 71, 10.1016/S0378-5955(02)00799-2 Ito, 1996, Immunolocalization of an inwardly rectifying K+ channel, K(AB)-2 (Kir4.1), in the basolateral membrane of renal distal tubular epithelia, FEBS Lett, 388, 11, 10.1016/0014-5793(96)00502-9 Kofuji, 2000, Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina, J Neurosci, 20, 5733, 10.1523/JNEUROSCI.20-15-05733.2000 Nichols, 1997, Inward rectifier potassium channels, Annu Rev Physiol, 59, 171, 10.1146/annurev.physiol.59.1.171 Anumonwo, 2010, Cardiac strong inward rectifier potassium channels, J Mol Cell Cardiol, 48, 45, 10.1016/j.yjmcc.2009.08.013 Barajas-Martinez, 2011, Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen–Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry, Circ Cardiovasc Genet, 4, 51, 10.1161/CIRCGENETICS.110.957696 de Boer, 2010, The anti-protozoal drug pentamidine blocks Kir2.x mediated inward rectifier current by entering the cytoplasmic pore region of the channel, Br J Pharmacol, 159, 1532, 10.1111/j.1476-5381.2010.00658.x Ponce-Balbuena, 2009, Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions, J Pharmacol Exp Ther, 331, 563, 10.1124/jpet.109.156075 López-Izquierdo, 2011, The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction, J Cardiovasc Pharmacol, 57, 407, 10.1097/FJC.0b013e31820b7c03 Ferrer, 2011, Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interaction, Eur J Pharmacol, 668, 72, 10.1016/j.ejphar.2011.05.067 López-Izquierdo, 2011, Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels, Pflugers Arch, 462, 505, 10.1007/s00424-011-0995-5 de Git, 2013, Cardiac ion cannel trafficking defects and drugs, Pharmacol Ther, 139, 24, 10.1016/j.pharmthera.2013.03.008 Barrett-Jolley, 1999, Direct block of native and cloned (Kir2.1) inward rectifier K+ channels by chloroethylclonidine, Br J Pharmacol, 128, 760, 10.1038/sj.bjp.0702819 Huang, 1998, Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma, Nature, 391, 803, 10.1038/35882 Pegan, 2005, Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification, Nat Neurosci, 8, 279, 10.1038/nn1411 Wible, 1994, Gating of inwardly rectifying K+ channels localized to a single negatively charged residue, Nature, 371, 246, 10.1038/371246a0 El Harchi, 2009, Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome, J Mol Cell Cardiol, 47, 743, 10.1016/j.yjmcc.2009.02.027